Stork Capital
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital, Hedge Funds, Real Estate, Fixed Income (Debt and Bonds)
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Germany, China, France, Italy, Denmark, United Arab Emirates, Switzerland, Spain, Luxembourg, Austria, Saudi Arabia, Turkey, Netherlands, Sweden, Belgium, Norway, Finland, Poland
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Real Estate
- Infrastructure
- Telecommunications
- Media
- Retail
- Life Sciences
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Product Research
Investment Size:
1,000,000 to 100,000,000 USD
Investor Details Founded: 2019
Stork Capital is an independent, Geneva-based, regulated asset manager established by the founders of Levant Capital and Cerus Advisors to provide investment management services to its founders, private clients, and family offices. The firm specializes in private equity and venture capital investments, particularly in the healthcare and biotechnology sectors. With over 100 years of combined experience in private banking and multi-family offices, the team has held senior positions at institutions such as UBS, Credit Suisse, Merrill Lynch, and Lombard Odier. Stork Capital offers clients access to private markets, including direct opportunities and sought-after third-party funds, with a diversified allocation to private equity, private credit, real estate, and hedge funds. The firm also provides traditional wealth management solutions, including portfolio management services, merchant banking services, and wealth planning services to address family governance and wealth transfer. Stork Capital utilizes best-in-class cloud-based technology to offer on-demand account consolidation and performance reporting to facilitate diversification and risk management across custodians. The firm's portfolio includes investments in companies like Shoreline Biosciences, a biotechnology company developing cellular immunotherapies, and Structure Therapeutics, a global biopharmaceutical company developing novel oral small molecule therapeutics. Stork Capital's team has over a hundred years of combined experience, managing portfolios through five economic cycles, and is committed to delivering long-term wealth management solutions and services for private clients.
Requirements
- Focus on healthcare and biotechnology sectors
- Preference for early-stage and growth-stage companies
- Interest in companies with innovative technologies and strong management teams
- Willingness to engage in active portfolio management and strategic guidance
- Alignment with Stork Capital's values and investment philosophy
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Shoreline Biosciences
- Structure Therapeutics
Mentioned In
-
$99.00
-
$39.95
-
$24.95
-
$19.95
-
$19.95
-
$24.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of Stork Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim